Lv3
230 积分 2025-09-15 加入
Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2天前
已完结
Mechanisms of Resistance to Antibody-Drug Conjugates
3天前
已完结
Covalent Inhibitor Screening for Targeting LOXL2: Studied by VirtualScreening and Experimental Validation
4天前
已完结
Mechanisms of resistance to antibody–drug conjugates in cancers
13天前
已完结
Antibody-drug conjugates as immuno-oncology agents in colorectal cancer: targets, payloads, and therapeutic synergies
14天前
已完结
Spotlight on ideal target antigens and resistance in antibody-drug conjugates: Strategies for competitive advancement
14天前
已完结
The neuroblastoma tumor microenvironment: From an in-depth characterization towards novel therapies
20天前
已完结
Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates
20天前
已关闭
Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates
20天前
已完结
Disruptive technologies: catching the wave
23天前
已完结
皖公网安备34019202002308
